ID

22440

Beschrijving

ODM derived from http://clinicaltrials.gov/show/NCT00185393

Link

http://clinicaltrials.gov/show/NCT00185393

Trefwoorden

  1. 09-12-11 09-12-11 -
  2. 04-06-17 04-06-17 - Martin Dugas
Geüploaded op

4 juni 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
18 Years and older
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
Non Hodgkin Lymphoma stage III or IV at timepoint of diagnosis
Beschrijving

NHL III/IV

Datatype

boolean

Alias
UMLS CUI [1,1]
C0024305
UMLS CUI [1,2]
C0280116
UMLS CUI [1,3]
C0280117
Patients who have achieved a remission after first line chemotherapy
Beschrijving

remission after first line chemotherapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0687702
UMLS CUI [1,2]
C2045825
No less than 6 weeks and no more than 12 weeks since last dose of chemotherapy
Beschrijving

6-12 weeks since last dose of chemotherapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C1531781
UMLS CUI [1,2]
C1442456
written informed consent
Beschrijving

consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Any other anticancer treatment for NHL except the preceding first line chemotherapy
Beschrijving

other anticancer treatment

Datatype

boolean

Alias
UMLS CUI [1]
C0478584
Prior radiation therapy
Beschrijving

Prior radiation therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0279134
Patients who have not recovered from the toxic effects of the first line chemotherapy
Beschrijving

no recovery from chemotherapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C1709277
UMLS CUI [1,2]
C0392920
Any other cancer or history of cancer less than 10 years ago
Beschrijving

other cancer

Datatype

boolean

Alias
UMLS CUI [1]
C1707251
Patients with known HIV positivity
Beschrijving

HIV

Datatype

boolean

Alias
UMLS CUI [1]
C0019682
patients with pleural effusion or ascites
Beschrijving

pleural effusion or ascites

Datatype

boolean

Alias
UMLS CUI [1,1]
C0032227
UMLS CUI [1,2]
C0003962
female patients who are pregnant or breast feeding (women of childbearing potential must have a negative serum pregnancy test at study entry)
Beschrijving

pregnant or breast feeding

Datatype

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
Adults not employing an effective method of birth control during study treatment and 12 months thereafter
Beschrijving

no contraception

Datatype

boolean

Alias
UMLS CUI [1]
C2919192
Patients unable or unwilling to comply with protocol
Beschrijving

non-compliance

Datatype

boolean

Alias
UMLS CUI [1]
C0457432

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years and older
boolean
C0001779 (UMLS CUI [1])
NHL III/IV
Item
Non Hodgkin Lymphoma stage III or IV at timepoint of diagnosis
boolean
C0024305 (UMLS CUI [1,1])
C0280116 (UMLS CUI [1,2])
C0280117 (UMLS CUI [1,3])
remission after first line chemotherapy
Item
Patients who have achieved a remission after first line chemotherapy
boolean
C0687702 (UMLS CUI [1,1])
C2045825 (UMLS CUI [1,2])
6-12 weeks since last dose of chemotherapy
Item
No less than 6 weeks and no more than 12 weeks since last dose of chemotherapy
boolean
C1531781 (UMLS CUI [1,1])
C1442456 (UMLS CUI [1,2])
consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
other anticancer treatment
Item
Any other anticancer treatment for NHL except the preceding first line chemotherapy
boolean
C0478584 (UMLS CUI [1])
Prior radiation therapy
Item
Prior radiation therapy
boolean
C0279134 (UMLS CUI [1])
no recovery from chemotherapy
Item
Patients who have not recovered from the toxic effects of the first line chemotherapy
boolean
C1709277 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
other cancer
Item
Any other cancer or history of cancer less than 10 years ago
boolean
C1707251 (UMLS CUI [1])
HIV
Item
Patients with known HIV positivity
boolean
C0019682 (UMLS CUI [1])
pleural effusion or ascites
Item
patients with pleural effusion or ascites
boolean
C0032227 (UMLS CUI [1,1])
C0003962 (UMLS CUI [1,2])
pregnant or breast feeding
Item
female patients who are pregnant or breast feeding (women of childbearing potential must have a negative serum pregnancy test at study entry)
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
no contraception
Item
Adults not employing an effective method of birth control during study treatment and 12 months thereafter
boolean
C2919192 (UMLS CUI [1])
non-compliance
Item
Patients unable or unwilling to comply with protocol
boolean
C0457432 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial